Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
50.40
+1.20 (2.44%)
Jun 6, 2025, 5:31 PM CET

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 618.31 million as of June 6, 2025. Its market cap has increased by 18.43% in one year.

Market Cap
618.31M
Enterprise Value
609.27M
Revenue
208.54M
Ranking
n/a
PE Ratio
8.65
Stock Price
50.40

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 618.31M, an increase of 15.94%. That is a compound annual growth rate of 0.70%.

History

DateMarket Cap% Change
Jun 6, 2025618.31M23.36%
Dec 30, 2024501.21M18.52%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Roche Holding AG 214.54B
Novartis AG 188.17B
Lonza Group AG 39.70B
Alcon 34.86B
Galderma Group AG 26.71B
Sandoz Group AG 18.28B
Straumann Holding AG 16.98B
Sonova Holding AG 15.16B
Market Cap Rankings